Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

Ipamorelin vs Sermorelin: GH Secretagogue Comparison

Ipamorelin vs Sermorelin compared: GH release mechanisms, evidence grades, dosing protocols, side effects, cost, and which growth hormone peptide is right for your research.

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

Ipamorelin vs Sermorelin: GH Secretagogue Comparison

Ipamorelin is a selective growth hormone releasing peptide (GHRP) that mimics ghrelin at the GHS receptor to trigger strong GH pulses with minimal cortisol and prolactin elevation. Sermorelin is a GHRH analog (first 29 amino acids of natural GHRH) that stimulates GH release through the GHRH receptor, more closely mimicking natural pituitary physiology. Both are used extensively in growth hormone optimization research and are frequently combined for synergistic effects.

Side-by-Side Comparison

Class

GHRP (Growth Hormone Releasing Peptide)

GHRH analog (Growth Hormone Releasing Hormone)

Mechanism

Ghrelin/GHS receptor agonist

GHRH receptor agonist

Evidence Grade

B+

Route

Subcutaneous injection

Typical Dose

200 - 300 mcg, 2-3x daily

200 - 500 mcg before bed

Half-Life

~2 hours

~10-20 minutes

GH Pulse Strength

Strong, consistent pulses

Moderate, physiological pulses

Cortisol Impact

Minimal (selective)

None

Prolactin Impact

Minimal

Appetite Effect

Minimal (unlike GHRP-6)

FDA History

Not FDA-approved

Previously FDA-approved (withdrawn 2008, commercial reasons)

Desensitization Risk

Low with proper cycling

Very low

Best Combined With

CJC-1295 (GHRH analog)

Ipamorelin or GHRP-2 (GHRP)

Cost (research grade)

$

$$

Ipamorelin: Pros & Cons

Advantages

Strongest, cleanest GHRP with minimal side effects

No significant cortisol or prolactin elevation

Minimal appetite stimulation (unlike GHRP-6)

Consistent, reproducible GH pulses

Low desensitization risk with cycling

Lower cost per dose than sermorelin

Considerations

Requires 2-3 injections per day for optimal results

Works through a single pathway (GHS receptor only)

No prior FDA approval history

Best results require combination with a GHRH analog

May cause mild water retention in some users

Sermorelin: Pros & Cons

Most physiological GH stimulation pattern

Previously FDA-approved (strong safety history)

No cortisol, prolactin, or appetite effects

Very low desensitization risk

Once-daily dosing (before bed) is adequate

Well-studied in clinical settings

Shorter half-life (~10-20 min) limits GH pulse duration

Lower peak GH release compared to GHRPs

Higher cost per dose than ipamorelin

Effectiveness decreases with age and pituitary decline

FDA approval was withdrawn (commercial, not safety reasons)

Which Is Right for Your Research?

Decision Guide

Choose Ipamorelin if: You want the strongest GH pulse per injection with the cleanest side effect profile among GHRPs. Ipamorelin is ideal for researchers seeking robust GH release without cortisol/prolactin interference. It is best combined with a GHRH analog (CJC-1295 or sermorelin itself) for maximum synergy.

Choose Sermorelin if: You prefer the most physiological approach to GH stimulation with the strongest regulatory safety history. Sermorelin more closely mimics natural GH secretion and is ideal for anti-aging, recovery, and sleep quality research. Its once-daily bedtime dosing is also more convenient.

Combine both if: Maximum GH optimization is the goal. The GHRP + GHRH combination (ipamorelin + sermorelin or CJC-1295) is the gold standard in peptide-based GH research, producing synergistic release greater than either compound alone.

Frequently Asked Questions

Ipamorelin tends to produce stronger, more consistent GH pulses per injection with fewer side effects. Sermorelin more closely mimics natural GHRH physiology but produces somewhat lower peak GH levels. Many researchers combine both for synergistic GH release through complementary receptor pathways.

Yes, combining ipamorelin (GHRP) with sermorelin (GHRH analog) is a well-established protocol. They work through different receptors, creating synergistic GH release greater than either alone. This is considered the gold standard for peptide-based GH optimization.

Ipamorelin is notable for minimal cortisol elevation, no significant prolactin increase, and minimal appetite stimulation. Sermorelin side effects include injection site reactions, facial flushing, headache, and occasional dizziness. Both are well-tolerated compared to exogenous HGH or other GHRPs like GHRP-6.

Related Protocol Guides

Verified Research Suppliers

Research-grade peptides are available from verified suppliers listed on our Vendor Comparison page. All listed vendors meet cGMP certification and third-party testing standards.

Related Tools & Resources

Related Resources

Connected topics

Follow this recovery question